NIH-funded research Fellowship grant

Investigating how nerve ablation can help treat high blood pressure

Official title: Evaluating the Mechanisms of Afferent Renal Nerve Ablation as a Treatment for Hypertension

Funded at University of Minnesota · NIH-10917044 · Data updated 2026-11-12

This study is testing a new way to help lower blood pressure for people with hypertension who haven't found relief with regular treatments by looking at a special type of nerve in the kidneys and seeing if removing them can make a difference.

More Hypertension research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startSeptember 1, 2023
Project endFebruary 28, 2026
Funding year2024
Award (this year)$49,324
NIH project number5F30HL167564-02
Project IDNIH-10917044 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with treatment-resistant hypertension who have not responded to lifestyle changes or medication.

Less likely to help

Patients with hypertension that is well-controlled through existing therapies may not benefit from this research.

What this research studies

This research explores a new treatment for hypertension by focusing on the role of afferent renal nerves, which are sensory nerves in the kidneys. The study aims to determine whether ablating these nerves can effectively lower blood pressure in patients who do not respond to traditional treatments. Using a novel method developed in the lab, researchers will compare the effects of afferent renal nerve ablation to total renal nerve ablation in a controlled setting. If successful, this approach could offer a new option for patients struggling with high blood pressure.

Why it matters

Potential benefit: If successful, this research could provide a new, effective treatment option for patients with resistant hypertension.

How similar studies have gone: Previous clinical trials have shown that renal nerve ablation can effectively lower blood pressure, suggesting that this approach may also be promising.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: De la Cruz-Lynch, Arthur Trenton — University of Minnesota
  • Study coordinator: De la Cruz-Lynch, Arthur Trenton

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.